NCT03573960 2026-03-06A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid CancerEisai Inc.Phase 4 Completed50 enrolled
NCT01496313 2025-10-03To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerSanofiPhase 4 Completed81 enrolled 15 charts